Carodyl Chewable

Pharmacological Properties

Carodyl Chewable belongs to the group of non-steroidal anti-inflammatory drugs (NSAIDs). Carprofen exhibits anti-inflammatory, analgesic, and antipyretic effects. Its action is associated with inhibition of cyclooxygenase (COX), resulting in reduced prostaglandin synthesis involved in pain, inflammation, and fever.

After oral administration, carprofen is well absorbed from the gastrointestinal tract. It is highly bound to plasma proteins, metabolized primarily in the liver, and excreted mainly via feces and, to a lesser extent, urine.

Indications for Use

Carodyl Chewable is indicated for the relief of inflammation and pain associated with acute and chronic musculoskeletal disorders, including osteoarthritis. It is also used for the control of postoperative pain following orthopedic or soft tissue surgery. Intended for use in dogs only.

Contraindications

Do not use in animals with hypersensitivity to carprofen or other NSAIDs. It is contraindicated in cases of gastrointestinal ulcers or bleeding, severe hepatic, renal, or cardiac impairment. Avoid use in dehydrated, hypovolemic, or hypotensive animals. Not recommended for puppies below the manufacturer’s specified minimum age or for pregnant and lactating animals unless under veterinary supervision.

Dosage and Method of Administration

Administer orally according to the dog’s body weight and veterinary instructions. The typical recommended dose is 4.4 mg/kg per day, given as a single dose or divided into two equal doses. Do not exceed the prescribed dosage or duration of treatment.

Adverse Reactions

In rare cases, vomiting, diarrhea, decreased appetite, or lethargy may occur. Very rarely, gastrointestinal ulceration, renal dysfunction, or liver enzyme elevations may develop. If adverse reactions are observed, discontinue use and consult a veterinarian immediately.

Overdose

Symptoms of overdose may include gastrointestinal disturbances, depression, or renal impairment. In case of overdose, initiate symptomatic and supportive treatment under veterinary supervision.

Special Warnings and Precautions

Do not administer concurrently with other NSAIDs or glucocorticoids. Ensure adequate hydration during treatment. Use with caution in elderly or debilitated animals. Veterinary monitoring is recommended during long-term therapy.

Disclaimer

This product is intended for use in animals only. Always follow the advice and instructions of a licensed veterinarian. The information provided here is for general guidance and does not replace professional veterinary consultation. Use only as directed. The manufacturer and distributor are not responsible for any adverse effects resulting from misuse, overdose, or off-label use of this product. Keep out of reach of children and animals other than those for which the product is intended. In case of accidental ingestion by humans, seek medical attention immediately.

Clinical Verification

Last Clinically Updated: August 15, 2026

Written By

Dr. Elena Vance, PharmD

Clinical Specialist in Neuropharmacology

Fact Checked By

Marcus Thorne, MS

Biomedical Data & FDA Label Verification

Medically Reviewed By

Dr. Arthur Campbell, MD

Board-Certified Psychiatrist (ABPN)